Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Sirtuin 7 promotes 45S pre-rRNA cleavage at site 2 and determines the processing pathway.

Sirri V, Grob A, Berthelet J, Jourdan N, Roussel P.

J Cell Sci. 2019 Sep 2;132(17). pii: jcs228601. doi: 10.1242/jcs.228601.

PMID:
31331964
2.

Sharing of mitotic pre-ribosomal particles between daughter cells.

Sirri V, Jourdan N, Hernandez-Verdun D, Roussel P.

J Cell Sci. 2016 Apr 15;129(8):1592-604. doi: 10.1242/jcs.180521. Epub 2016 Feb 29.

3.

The nucleolus: structure/function relationship in RNA metabolism.

Hernandez-Verdun D, Roussel P, Thiry M, Sirri V, Lafontaine DL.

Wiley Interdiscip Rev RNA. 2010 Nov-Dec;1(3):415-31. doi: 10.1002/wrna.39. Epub 2010 Sep 22. Review.

PMID:
21956940
4.

Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells.

Orecchia A, Scarponi C, Di Felice F, Cesarini E, Avitabile S, Mai A, Mauro ML, Sirri V, Zambruno G, Albanesi C, Camilloni G, Failla CM.

PLoS One. 2011;6(9):e24307. doi: 10.1371/journal.pone.0024307. Epub 2011 Sep 12. Erratum in: PLoS One. 2011;6(10). doi:10.1371/annotation/0174b439-c62b-42e8-a420-3defbfe5c8e9.

5.

The NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeats.

Guetg C, Lienemann P, Sirri V, Grummt I, Hernandez-Verdun D, Hottiger MO, Fussenegger M, Santoro R.

EMBO J. 2010 Jul 7;29(13):2135-46. doi: 10.1038/emboj.2010.17. Epub 2010 Feb 18. Erratum in: EMBO J. 2010 Jul 7;29(13):2253.

6.

Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis.

Grob A, Roussel P, Wright JE, McStay B, Hernandez-Verdun D, Sirri V.

J Cell Sci. 2009 Feb 15;122(Pt 4):489-98. doi: 10.1242/jcs.042382. Epub 2009 Jan 27.

7.

Nucleolus: the fascinating nuclear body.

Sirri V, Urcuqui-Inchima S, Roussel P, Hernandez-Verdun D.

Histochem Cell Biol. 2008 Jan;129(1):13-31. Epub 2007 Nov 29. Review.

8.

A B23-interacting sequence as a tool to visualize protein interactions in a cellular context.

Lechertier T, Sirri V, Hernandez-Verdun D, Roussel P.

J Cell Sci. 2007 Jan 15;120(Pt 2):265-75. Epub 2006 Dec 19.

9.

MyoD undergoes a distinct G2/M-specific regulation in muscle cells.

Batonnet-Pichon S, Tintignac LJ, Castro A, Sirri V, Leibovitch MP, Lorca T, Leibovitch SA.

Exp Cell Res. 2006 Dec 10;312(20):3999-4010. Epub 2006 Sep 8.

PMID:
17014844
10.

Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.

Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP, Leibovitch SA.

J Biol Chem. 2005 Jan 28;280(4):2847-56. Epub 2004 Nov 5.

11.

Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.

Tintignac LA, Sirri V, Leibovitch MP, Lécluse Y, Castedo M, Metivier D, Kroemer G, Leibovitch SA.

Mol Cell Biol. 2004 Feb;24(4):1809-21.

12.
13.

Cyclin-dependent kinases govern formation and maintenance of the nucleolus.

Sirri V, Hernandez-Verdun D, Roussel P.

J Cell Biol. 2002 Mar 18;156(6):969-81. Epub 2002 Mar 18.

14.

Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.

David-Pfeuty T, Nouvian-Dooghe Y, Sirri V, Roussel P, Hernandez-Verdun D.

Oncogene. 2001 Sep 20;20(42):5951-63.

15.

Nucleolar size indicates the rapidity of cell proliferation in cancer tissues.

Derenzini M, Trerè D, Pession A, Govoni M, Sirri V, Chieco P.

J Pathol. 2000 Jun;191(2):181-6.

PMID:
10861579
16.
17.

The AgNOR proteins: qualitative and quantitative changes during the cell cycle.

Sirri V, Roussel P, Hernandez-Verdun D.

Micron. 2000 Apr;31(2):121-6.

PMID:
10588057
18.
19.

Nucleolar function and size in cancer cells.

Derenzini M, Trerè D, Pession A, Montanaro L, Sirri V, Ochs RL.

Am J Pathol. 1998 May;152(5):1291-7.

20.

Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease.

Licastro F, Sirri V, Trerè D, Davis LJ.

Dement Geriatr Cogn Disord. 1997 Nov-Dec;8(6):337-42.

PMID:
9370085
21.

Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent.

Sirri V, Roussel P, Gendron MC, Hernandez-Verdun D.

Cytometry. 1997 Jun 1;28(2):147-56.

PMID:
9181305
22.

Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis.

Trerè D, Derenzini M, Sirri V, Montanaro L, Grigioni W, Faa G, Columbano GM, Columbano A.

Hepatology. 1996 Nov;24(5):1269-73.

PMID:
8903409
23.

Proportionally constant quantitative transmission of nucleolin and protein B23 in cycling cancer cells.

Sirri V, Pession A, Trerè D, Montanaro L, Derenzini M.

Clin Mol Pathol. 1995 Oct;48(5):M264-8.

24.

The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.

Derenzini M, Sirri V, Trerè D, Ochs RL.

Lab Invest. 1995 Oct;73(4):497-502.

PMID:
7474921
25.

Amount variability of total and individual Ag-NOR proteins in cells stimulated to proliferate.

Sirri V, Roussel P, Trerè D, Derenzini M, Hernandez-Verdun D.

J Histochem Cytochem. 1995 Sep;43(9):887-93.

PMID:
7642962
26.

Quantitative changes of the two major AgNOR proteins, nucleolin and protein B23, related to stimulation of rDNA transcription.

Derenzini M, Sirri V, Pession A, Trerè D, Roussel P, Ochs RL, Hernandez-Verdun D.

Exp Cell Res. 1995 Jul;219(1):276-82.

PMID:
7628543
27.

Quantification of Ag-NOR proteins using Ag-NOR staining on western blots.

Roussel P, Sirri V, Hernandez-Verdun D.

J Histochem Cytochem. 1994 Nov;42(11):1513-7.

PMID:
7930534

Supplemental Content

Support Center